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a b s t r a c t
Fluorescence properties of the antitumoral methyl 3-(benzo[b]thien-2-yl)-benzothieno[3,2-b]pyrrole-2-
carboxylate (BTP)were studied in solutionand in lipidbilayersofdipalmitoylphosphatidylcholine (DPPC),
dioleoyl phosphatidylethanolamine (DOPE) and egg yolk phosphatidylcholine (Egg-PC). BTP presents
good ﬂuorescence quantum yields in all solvents studied (0.20≤˚F ≤0.32) and a bathochromic shift in
polar solvents. The results indicate an ICT character of the excited state, with an estimated dipolemoment
of e = 7.38D.
Fluorescence (steady-state) anisotropymeasurements ofBTP incorporated in lipidmembranes ofDPPC,
DOPE and Egg-PC indicate that this compound is deeply located in the lipid bilayer, feeling the difference
between the rigid gel phase and ﬂuid phases.
BTP inhibits the growth of three human tumour cell lines, MCF-7 (breast adenocarcinoma), SF-268
(glioma) andNCI-H460 (non-small cell lung cancer), being signiﬁcantlymorepotent against theNCI-H460
tumour cells.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
Thienopyrroles are a very important class of biologically active
compounds with antiviral [1] and anti-inﬂammatory properties
[2]. Thienopyrroles have been widely used as sPLA2 inhibitors [3],
MCP-1 antagonists [4] and glycogen phosphorylase inhibitors [5].
This type of compounds has also been described as gonadotrophin
releasing hormone antagonists [6] and as bioisosteric analogues of
tryptamine derivatives [7].
Due to their broad spectrum of biological activity, strong
research efforts have been devoted to the synthesis of thienopy-
rroles and their derivatives [8]. The skeleton benzothieno[3,2-
b]pyrrole had already been synthesized by Iddon et al. [9] but, as
far as our knowledge, no biological activity data have been reported
on this type of compounds.
Abbreviations: DPPC, dipalmitoyl phosphatidylcholine; DOPE, dioleoyl phos-
phatidylethanolamine; Egg-PC, egg yolk phosphatidylcholine; PC, phosphatidyl-
choline; PE, phosphatidylethanolamine.
∗ Corresponding author. Tel.: +351 253 604321; fax: +351 253 604061.
E-mail addresses: ecoutinho@ﬁsica.uminho.pt, emsccoutinho@gmail.com
(E.M.S. Castanheira).
Recently, some of us have synthesized several ﬂuores-
cent (benzo[b]thienyl)benzothienopyrroles [10]. One of these
compounds, a methyl 3-(benzo[b]thien-2-yl)benzothieno[3,2-
b]pyrrole-2-carboxylate (BTP) (Fig. 1) revealed promising antitu-
mour properties, with a inhibitory activity of the in vitro growth
of three human tumour cell lines, MCF-7 (breast adenocarci-
noma), SF-268 (CNS cancer) and NCI-H460 (non-small cell lung
cancer). The best anti-proliferative result was obtained for NCI-
H460 cell line, with a very low GI50 value (concentration needed
for 50% of cell growth inhibition) around 3.9M, as reported
here.
These promising results suggested us to perform ﬂuorescence
studies of BTP incorporated in lipid membranes. The photo-
physical properties of BTP in solution and in lipid bilayers
of neutral phospholipid components of biological membranes,
DPPC (dipalmitoyl phosphatidylcholine), DOPE (dioleoyl phos-
phatidylethanolamine) and Egg-PC (egg yolk phosphatidylcholine)
were studied. Fluorescence (steady-state) anisotropy measure-
mentswere also performed to obtain further information about the
behaviour of BTP in lipid membranes. These studies are important,
keeping in mind the incorporation of this compound in liposomes
for controlled drug delivery systems. In fact, liposomes have been
widely used to deliver anticancer agents, in order to reduce the
1010-6030/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
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Fig. 1. Structure of the benzothieno[3,2-b]pyrrole (BTP) studied.
toxic effects of the drugs when given alone or to increase the drug
circulation time and effectiveness [11].
2. Experimental
2.1. Materials and methods
All the solutions were prepared using spectroscopic grade
solvents and ultrapure water (Milli-Q grade). 1,2-Dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC), 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE), and 1,2-diacyl-sn-glycero-3-
phosphocholine fromeggyolk (Egg-PC)wereobtained fromSigma–
Aldrich (lipid structures are shown below).
For DOPE and Egg-PC membranes preparation, deﬁned vol-
umes of stock solutions of lipid (26.9mM for DOPE and 34.5mM
for Egg-PC) and BTP (0.2mM) in ethanol were injected together,
under vigorous stirring, to an aqueous buffer solution (10mM Tris,
1mM EDTA, pH 7.4), at room temperature. A similar procedure was
adopted forDPPCvesicles, but the injectionof the required amounts
of stock solutions of lipid (50mM) and BTP in ethanol was done at
60 ◦C, well above the melting transition temperature of DPPC (ca.
41 ◦C) [12]. In all cases, the ﬁnal lipid concentrationwas 1mM,with
a BTP/lipid molar ratio of 1:500.
2.2. Spectroscopic measurements
Absorption spectra were recorded in a Shimadzu UV-3101PC
UV-Vis-NIR spectrophotometer. Fluorescence measurements were
performed using a Fluorolog 3 spectroﬂuorimeter, equipped
with double monochromators in both excitation and emission,
Glan–Thompson polarizers and a temperature controlled cuvette
holder. Fluorescence spectra were corrected for the instrumental
response of the system.
For ﬂuorescence quantum yield determination, the solutions
were previously bubbled for 20min with ultrapure nitrogen. The
ﬂuorescence quantum yields (˚s) were determined using the stan-
dard method (Eq. (1)) [13,14]. 9,10-Diphenylanthracene in ethanol
was used as reference, ˚r =0.95 [15]:
˚s =
[
ArFsn2s
AsFrn2r
]
˚r (1)
where A is the absorbance at the excitation wavelength, F the inte-
grated emission area andn the refraction index of the solvents used.
Subscripts refer to the reference (r) or sample (s) compound. The
absorbance value at excitationwavelengthwas always less than 0.1,
in order to avoid inner ﬁlter effects.
Solvatochromic shifts were described by the Lippert–Mataga
equation (2), which relates the energy difference between absorp-
tion and emission maxima to the orientation polarizability [16,17]:
¯abs − ¯ﬂ =
1
4ε0
22
hcR3
f + const (2)
where ¯abs is the wave number of maximum absorption, ¯ﬂ is
the wave number of maximum emission, =e –g is the
difference in the dipole moment of solute molecule between
excited (e) and ground (g) states, R is the cavity radius (consider-
ing the ﬂuorophore a point dipole at the center of a spherical cavity
immersed in the homogeneous solvent), and f is the orientation
polarizability given by (Eq. (3)):
f = ε − 1
2ε + 1 −
n2 − 1
2n2 + 1 (3)
where ε is the static dielectric constant and n the refractive index
of the solvent.
The steady-state ﬂuorescence anisotropy, r, is calculated by:
r = IVV − GIVH
IVV + 2GIVH
(4)
where IVV and IVH are the intensities of the emission spectra
obtained with vertical and horizontal polarization, respectively
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(for vertically polarized excitation light), and G= IHV/IHH is the
instrument correction factor, where IHV and IHH are the emission
intensities obtained with vertical and horizontal polarization (for
horizontally polarized excitation light).
2.3. Biological activity
2.3.1. Materials
Fetal bovine serum (FBS) and l-glutamine were obtained from
Gibco Invitrogen Co. (Scotland, UK). RPMI-1640 medium was from
Cambrex (New Jersey, USA). Dimethylsulfoxide (DMSO), doxoru-
bicin, penicillin, streptomycin and sulforhodamine B (SRB) were
from Sigma Chemical Co. (Saint Louis, USA).
Stock solution of BTPwas prepared in DMSO and kept at −20 ◦C.
Appropriate dilutions of the compound were freshly prepared just
prior to the assays. Final concentrations of DMSO did not interfere
with the cell lines growth.
2.3.2. Cell cultures
Three human tumour cell lines, MCF-7 (breast adenocarci-
noma), SF-268 (glioma) and NCI-H460 (non-small cell lung cancer)
were used. MCF-7 was obtained from the European Collection of
Cell Cultures (ECACC, Salisbury, UK). SF-268 and NCI-H460 were
kindly provided by the National Cancer Institute (NCI, Bethesda,
USA). Cells were grown as monolayer and routinely maintained in
RPMI-1640 medium supplemented with 5% heat inactivated FBS,
2mM glutamine and antibiotics (penicillin 100U/ml and strepto-
mycin 100g/ml), at 37 ◦C in a humidiﬁed atmosphere containing
5% CO2. Exponentially growing cells were obtained by plating
1.5×105 cells/ml for MCF-7 and SF-268 and 0.75×105 cells/ml for
NCI-H460, followed by 24h incubation. The effect of the vehicle
solvent (DMSO) on the growth of these cell lines was evaluated
in all the experiments by exposing untreated control cells to the
maximum concentration (0.5%) of DMSO used in each assay.
2.3.3. Tumour cells growth assay
The effect of BTP on the in vitro growth of human tumour cell
lines was evaluated according to the procedure adopted by the
National Cancer Institute (NCI, USA) in the “In vitro Anticancer
Drug Discovery Screen” that uses the protein-binding dye sulforho-
damine B to assess cell growth [18–19]. Brieﬂy, exponentially cells
growing in 96-well plates were exposed for 48h to ﬁve serial
concentrations of BTP, starting from a maximum concentration
of 150M. Following this exposure period, adherent cells were
ﬁxed, washed and stained. The bound stain was solubilized and
the absorbance was measured at 492nm in a plate reader (BioTek
Instruments Inc., Powerwave XS, Winooski, USA). A dose–response
curve was obtained and the growth inhibition of 50% (GI50), cor-
responding to the concentration of BTP that inhibited 50% of the
net cell growth was calculated as described elsewhere [19]. Dox-
orubicin used as a positive control was tested in the same manner.
3. Results and discussion
3.1. Antitumoral properties of BTP
The effect of the benzothienopyrrole BTP on the in vitro growth
of three human tumour cell lines, MCF-7 (breast adenocarcinoma),
SF-268 (CNS cancer) and NCI-H460 (non-small cell lung cancer),
was evaluated after a continuous exposure of 48h. Results given in
concentrations thatwere able to cause 50% of cell growth inhibition
(GI50) are summarized in Table 1.
It can be observed in Table 1 that BTP inhibited the growth of
all the three human tumour cell lines, but it was signiﬁcantly much
more potent against the lung cancer NCI-H460 cell line, present-
ing a very low GI50 value (3.9±0.3M). BTP presents GI50 values
Table 1
Values of BTP concentration needed for 50% of
cell growth inhibition (GI50) for three human
tumour cell lines.
Cell line GI50 (M)
MCF-7 19.1 ± 11.5
SF-268 38.7 ± 8.9
NCI-H460 3.9 ± 0.3
Results represent means± SEM of 3–4 inde-
pendent experiments performed in duplicate.
Doxorubicin was used as positive control, GI50:
MCF-7=42.8±8.2nM; SF-268=94.0±7.0nM
and NCI-H460=94.0±8.7nM.
lower or of the samemagnitudeof other compounds recently tested
in the same tumour cell lines and also considered as potential anti-
tumorals [20,21]. The BTP different cell line response may reﬂect a
possible tumour type-speciﬁc sensitivity of this compound which
is very important for its potential use in the treatment of this type
of tumour.
Doxorubicin, used as positive control, presents a very high cyto-
toxicity because the planar aromatic part efﬁciently intercalates
into DNA base pairs, while the six-membered daunosamine sugar
binds to the minor groove, interacting with ﬂanking base pairs
adjacent to the intercalation site [22]. Nevertheless, doxorubicin
presents also a high toxicity for the human body and the search for
other antitumour compounds even less active but also less toxic is
still an active domain of interest.
3.2. Photophysical properties of BTP in solution
The absorption and ﬂuorescence properties of BTP were ﬁrst
studied in several solvents. The maximum absorption (abs) and
emission (em) wavelengths, molar extinction coefﬁcients and ﬂu-
orescence quantum yields are presented in Table 2.
In pyrrole and its derivatives, the heteronitrogen is singly
bonded to carbon atoms in the heterocycle. The transitions involv-
ing the non-bonding electrons have properties similar to those
of  →* transitions, as the non-bonding orbital is perpendic-
ular to the plane of the ring, which allows it to overlap the 
orbitals on the adjacent carbon atoms [23]. BTP compound also
presents a carboxylate group and it is known that many carbonyl
compounds exhibit low ﬂuorescence quantum yields due to the
low-lying n→* state. In BTP, it is possible that the electronic
transitions  →* and n→* can be nearby in energy, resulting
in state-mixing [24]. A predominance of  →* character could
explain the high ε values (ε>104 M−1 cm−1) and the very reason-
able ﬂuorescence quantum yields (Table 2).
The normalized ﬂuorescence spectra of BTP are shown in Fig. 2.
Examples of absorption spectra are shown as inset.
A red shift can be observed from cyclohexane to more polar
solvents, especially in ﬂuorescence spectra. A complete loss of
vibrational structure is also observed for the emission in polar sol-
vents (Fig. 2), which is usually related to an intramolecular charge
transfer (ICT) mechanism and/or to speciﬁc solvent effects [16].
This behaviour was already observed by us for tetracyclic ben-
zothiophene derivatives, a thieno--carboline and a methoxylated
benzothieno[2,3-c]quinolone, synthesized by our group [25,26].
The Lippert–Mataga plot (Eq. (2)) for BTP, shown in Fig. 3, is
reasonably linear in non-protic solvents, alcohols and chloroform
exhibiting large positive deviations.
This behaviour in alcohols and chloroform can be attributed
to speciﬁc solute–solvent interactions by hydrogen bonds. The
formation of hydrogen bonds between chloroform and proton
acceptors is known since a long time [28]. In fact, BTP has the
capability of hydrogen bonding formation through the ester group
Author's personal copy
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Table 2
Maximumabsorption (abs) and emissionwavelengths (em),molar extinction coef-
ﬁcients (ε) and ﬂuorescence quantum yields (˚F) for BTP in several solvents.
Solvent abs (nm) (ε (M−1 cm−1)) em (nm) ˚Fa
Cyclohexane
320 sh (2.33×104)
396 0.31
294 (3.30×104)
264 (3.10×104)
230 (3.26×104)
Dioxane
321 sh (2.59×104)
398 0.29
297 (3.81×104)
263 (3.36×104)
228 (4.15×104)
Diethyl ether
322 sh (1.67×104)
396 0.20
294 (2.46×104)
263 (2.03×104)
231 (1.92×104)
Ethyl acetate
324 sh (1.67×104)
399 0.32295 (2.57×104)b
Dichloromethane
326 sh (2.62×104)
401 0.27
296 (3.79×104)
265 (3.36×104)
226 (4.35×104)
Chloroform
328 sh (1.70×104)
406 0.30297 (2.30×104)
266 (2.10×104)b
Acetonitrile
326 sh (2.24×104)
399 0.23
294 (3.50×104)
262 (2.94×104)
228 (3.54×104)
N,N-Dimethylformamide
328 sh (3.09×104)
402 0.29297 (4.86×104)b
Dimethylsulfoxide
331 sh (3.20×104)
406 0.29299 (5.04×104)b
Ethanol
327 sh (2.73×104)
407 0.20
295 (4.24×104)
264 (3.50×104)
229 (4.03×104)
Methanol
328 sh (2.91×104)
411 0.20
294 (4.47×104)
263 (3.76×104)
228 (4.36×104)
sh, shoulder.
a Relative to 9,10-diphenylanthracene in ethanol (˚r = 0.95 [15]). Error about 10%.
b Solvents cut-off: chloroform, 250nm; ethyl acetate, 265nm; dimethylsulfoxide,
270nm; N,N-dimethylformamide, 275nm.
(acceptor), the two S atoms (acceptors) and also the pyrrolic NH
group (donor).
From ab initio molecular quantum chemistry calculations, the
cavity radius (R) and ground state dipole moment (g) were
determined, through an optimized structure provided by GAMESS
software [29], using a RHF/3-21G(d) basis set [30] (Fig. 4). The BTP
optimized geometry shows that the benzo[b]thienyl substituent of
the molecule is almost perpendicular to the benzothienopyrrole
system. A cavity radius of 7.9Å and a ground state dipole moment
of 1.24 Dwere obtained, allowing the estimation of an excited-state
dipolemoment ofe = 7.38D from the Lippert–Mataga plot. Thise
value points to the presence of an intramolecular charge transfer
(ICT) mechanism occurring in the planar benzothienopyrrole moi-
ety, although not very pronounced. Twisted intramolecular charge
transfer states (TICT) usually exhibit signiﬁcantly higher excited-
state dipole moments (≥20D) [31] than the value obtained for BTP.
Fig. 5 reports the representation of BTP HOMO and LUMO
molecular orbitals. It can be observed that both molecular orbitals
are localized on the benzothienopyrrole moiety and also on the
methylester group. The HOMO–LUMO transition exhibits a charge
transfer from the S atom of the benzothienopyrrole system to both
Fig. 2. Normalized ﬂuorescence spectra (at peak of maximum emission) of
3×10−6 M solutions of BTP in several solvents (exc = 325nm) (Cyhex, cyclo-
hexane; Ether, diethyl ether; Diox, dioxane; DCM, dichloromethane; DMF,
N,N-dimethylformamide; DMSO, dimethylsulfoxide; EtAc, ethyl acetate; ACN, ace-
tonitrile; CLF, chloroform; EtOH, ethanol; MeOH, methanol). Inset: absorption
spectra of 2×10−5 M solutions of BTP in cyclohexane and ethanol, as examples (cell
path=1.0 cm).
Fig. 3. Lippert–Mataga plot for BTP: (1) cyclohexane; (2) dioxane; (3) chloroform;
(4) diethyl ether; (5) ethyl acetate; (6) dichloromethane; (7) dimethylsulfoxide; (8)
N,N-dimethylformamide; (9) acetonitrile; (10) ethanol; (11) methanol (values of ε
and n were obtained from Ref. [27]).
Fig. 4. Optimized structure of BTP (obtained by GAMESS software).
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Fig. 5. Representation of HOMO (lower) and LUMO (upper) molecular orbitals of
BTP.
the nitrogen and the OMe oxygen, conﬁrming the ICT character of
the excited state.
The benzo[b]thienyl substituent does not contribute to increase
non-radiative deactivation pathways in BTP. This justiﬁes the rea-
sonable ﬂuorescence quantum yields obtained (between 20% and
32%, Table 2), despite the presence of two S atoms in the molecule,
which usually lead to the increase of singlet–triplet intersystem
crossing by enhancement of spin–orbit coupling interaction [24].
The contribution of S atoms to decrease the ﬂuorescence quan-
tum yield is less important for BTP than for other analogues like
benzothienoindoleswith a dibenzothienyl substituent already syn-
thesized and studied by us [32].
3.3. Interaction of BTP with lipid membranes
Due to its promising antitumoral activity, photophysical studies
of BTP incorporated in lipid bilayers were also performed. These
studies are relevant to evaluate the interaction of the compound
with lipidmembranes. Assessmentof the localizationofBTP in lipid
vesicles is also important, pointing to drug delivery applications
using liposomes.
Different types of phospholipid molecules, DPPC, Egg-PC and
DOPE, were used for vesicle preparation. At room temperature,
DPPC (16:0 PC) is in the ordered gel phase, where the hydrocar-
bon chains are fully extendedandcloselypacked.Above themelting
transition temperature, Tm =41 ◦C [12], DPPC attains the disordered
liquid-crystalline phase. DOPE (18:1 PE) exhibits a very lowmelting
transition temperature (Tm =−16 ◦C [33]) and presents a lamellar
bilayer to inverse hexagonal (L–HII) phase transition at 3.3 ◦C [34].
Egg-PC is anaturalphospholipidmixture,wheremoleculeshave the
same polar head group (phosphatidylcholine) and different hydro-
carbon chains, differing in length and degree of unsaturation. Main
components are 16:0 PC, 18:0 PC and 18:1 PC [35]. Therefore, at
room temperature, Egg-PC is in the ﬂuid liquid-crystalline phase.
Fig. 6. Normalized ﬂuorescence spectra of BTP in lipid membranes of DOPE, Egg-PC
and DPPC (exc = 325nm). Inset: ﬂuorescence spectra of BTP in cyclohexane (Cyhex)
and ethanol (EtOH), at 25 and 55 ◦C.
In DPPC vesicles at gel phase (25 ◦C), the emission spectrum
of BTP is very similar in shape and position to those in cyclo-
hexane and diethyl ether (Fig. 6 and Table 3), indicating that BTP
is located deeply inside the lipid bilayer. When DPPC is in the
liquid-crystalline phase (at 55 ◦C), a structureless and red-shifted
emission is observed, similar to the spectra obtained in dioxane
and ethyl acetate. A decrease in emission intensity of about 25% is
also detected.
Inhomogeneous solution, theeffectof increasing temperature in
the ﬂuorescence ofBTP is a 10% intensity reduction and a very small
blue shift (ca. 1 nm). The inset of Fig. 6 shows BTP emission spectra
in cyclohexane and ethanol at 25 and 55 ◦C, where it can be seen
that the spectral shape is roughly the same at both temperatures.
The red shift and loss of vibrational structure of BTP emission
in lipid membranes at ﬂuid phases (DOPE and Egg-PC at 25 ◦C and
DPPC at 55 ◦C) point to a higher penetration of water molecules in
the vesicle bilayer, as lipid hydrocarbon chains are randomly ori-
ented and ﬂuid. However, it is also possible that in ﬂuid phases BTP
locates in a more polar environment, near the ester groups of the
phospholipid molecules.
Fluorescence anisotropy measurements can give further infor-
mation about BTP behaviour in lipid membranes. Steady-state
anisotropy relates to both the excited-state lifetime and the rota-
tional correlation time of the ﬂuorophore [23]:
1
r
= 1
r0
(
1 + 
c
)
(5)
where r0 is the fundamental anisotropy,  is the excited-state life-
time and c is the rotational correlation time.
The ﬂuorescence steady-state anisotropies and ﬂuorescence
quantum yields of BTP in lipid bilayers are shown in Table 3.
Table 3
Steady-state ﬂuorescence anisotropy (r) values, ﬂuorescence quantum yields and
maximum emission wavelengths (em) of BTP in lipid membranes. Values in ethy-
lene glycol at room temperature are also shown for comparison.
em (nm) ˚Fa r
Egg-PC (25 ◦C) 400 0.24 0.046
DOPE (25 ◦C) 399 0.27 0.023
DPPC (25 ◦C) 397 0.26 0.058
DPPC (55 ◦C) 399 0.11 0.036
Ethylene glycol (25 ◦C) 415 0.29 0.036
a Relative to 9,10-diphenylanthracene in ethanol (˚r = 0.95 [15]). Error about 10%.
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Fig. 7. Absorption spectra of BTP (2×10−6 M) in lipid membranes of DOPE, Egg-PC
and DPPC at both gel (25 ◦C) and liquid-crystalline phases (55 ◦C).
Anisotropy and quantum yield values in ethylene glycol at room
temperature were also determined for comparison.
Fluorescence quantum yields are roughly similar in all lipid
bilayers and in ethyleneglycol at 25 ◦C,with a small decrease inEgg-
PC. The Strickler–Berg equation [36] relates the radiative lifetime
with the absorption intensity (Eq. (6)):
1
r
= 2.88 × 10−9n2
∫
F¯(¯F) d¯F∫
¯−3F F¯(¯F) d¯F
∫
ε(¯A) d¯A
¯A
(6)
where r is the radiative lifetime, n is the refraction index, ε is the
molar extinction coefﬁcient, and F¯(¯F) is the ﬂuorescence intensity
perunitwavenumber,which is related to theﬂuorescencequantum
yield [23] (Eq. (7)):∫ 0
∞
F¯(¯F) d¯F = ˚F (7)
Absorption spectra of BTP in the various lipid membranes at 25 ◦C
(Fig. 7) are similar in the lowest energy absorption band. The
Stickler–Berg relation (Eq. (6)) predicts an approximately constant
value for the radiative lifetime in the three lipid membranes, con-
sidering the very small variations of the measured ﬂuorescence
quantum yields (Table 3).
The relation between the ﬂuorescence quantum yield and the
excited-state lifetime:
˚F = kr (8)
where kr = 1/r is the rate constant for radiative deactivation with
ﬂuorescence emission, allows the conclusion that the excited-state
lifetimes are approximately constant for the studied lipid systems
at 25 ◦C. Therefore, variations in ﬂuorescence anisotropy values at
this temperature can be directly related to changes in the rota-
tional correlation time of the ﬂuorophore and, thus, to changes in
the microviscosity of the surrounding medium of the ﬂuorescent
molecule. It can be observed that r values in DPPC at gel phase
(25 ◦C) and in Egg-PC are higher than the one obtained in ethylene
glycol, indicating that BTP is deeply located in the lipid bilayer. The
steady-state anisotropy in Egg-PC is higher than expected, compar-
ing all anisotropy values in lipid bilayers at ﬂuid phases (Egg-PC,
DOPE andDPPC at 55 ◦C). A similar behaviour in Egg-PCwas already
observed for indole-2-carboxylate derivatives, prepared by us, sub-
stituted in the 3-position with either a dibenzothiophene or a
dibenzofuran [37].
The phospholipid DOPE, at room temperature, adopts the
inverse hexagonal phase, where the lipid molecules can adopt
inverse curvature at the interface, allowing the chains to expand
and at the same time reduce the head group area at the interface
[38]. The very low anisotropy value observed in DOPE (Table 3)
reﬂects the different geometry of self-organized DOPE aggregates,
through the mentioned chain expansion. The emission spectrum
(Fig. 6) shows that BTP feels a similar environment in DOPE to that
in Egg-PC and DPPC at the liquid-crystalline phase.
InDPPC at 55 ◦C, a signiﬁcant ﬂuorescence quenching (Table 3) is
observeddue to the increaseof thenon-radiativedeactivationpath-
ways at higher temperatures. According to Eq. (5), an increase of the
steady-state anisotropy is predicted from a decrease of the excited-
state lifetime. BTP exhibits a signiﬁcant decrease in anisotropy
in DPPC at 55 ◦C (Table 3), showing that this molecule detects
the phospholipid gel to liquid-crystalline phase transition and the
associated decrease of microviscosity. The anisotropy value in the
DPPC ﬂuid phase is similar to the one in ethylene glycol at 25 ◦C,
as observed in heteroaryl and heteroannulated indoles [37]. The
results obtained inDPPC vesicles clearly indicate thatBTP is located
deeply in the lipid bilayer and that the red shift in emission at 55 ◦C
may be due to the higher water penetration and not to a different
localization of BTP in ﬂuid phases.
Liposomes have been widely employed to deliver anticancer
agents. Considering the BTP antitumoral activity and its preferen-
tial location near the phospholipid tails of lipid membranes, these
studies are also important to drug delivery assays using liposomes.
4. Conclusions
The methyl 3-(benzo[b]thien-2-yl)benzothieno[3,2-b]pyrrole-
2-carboxylate (BTP) interferes with the growth of different human
tumour cell lines, exhibiting a stronger effect against the NCI-H460
lung cancer cell line.
This compound shows a solvent sensitive ﬂuorescence emission
and very reasonable ﬂuorescence quantum yields (20–32%) in both
polar and non-polar solvents. The estimated excited-state dipole
moment (7.38D) points to an ICT character of the excited state,
conﬁrmed by molecular quantum chemistry calculations.
Studies of incorporation in lipid bilayers revealed that BTP pref-
erential location is near the hydrophobic lipid tails. Overall, these
results point to a promising use of BTP as an antitumoral drug with
the possibility of being transported in the hydrophobic region of
liposomes.
Acknowledgements
We acknowledge the Foundation for the Science and Tech-
nology (FCT) – Portugal and FEDER (European Communitarian
Fund) for ﬁnancial support to Centro de Física and Cen-
tro de Química of Minho University, through the project
PTDC/QUI/81238/2006. Computational facilities supported by FCT
and University of Minho under project SeARCH (ref. REEQ/443/
EEI/2005) are also acknowledged. A.S.A. acknowledges FCT for a
post-doc. Grant SFRH/BPD/24548/2005.
References
[1] (a) B. Attenni, J.I.M. Hernando, S. Malancona, F. Narjes, J. M. Ontoria Ontoria,
M. Rowley, Thienopyrroles as Antiviral Agents, Istituto di Ricerche di Biologia
Molecolare P Angeletti S.p.A., Italy, WO/2005/023819, 2005.;
(b) S. Colarusso, J. Habermann, F. Narjes, S. Ponzi, M.R. Rico Ferreira, Thienopy-
rroles as Antiviral Agents, Istituto di Ricerche di BiologiaMolecolare P Angeletti
S.p.A., Italy, WO/2006/119975, 2006.
[2] B. Pelcman, K. Olofsson, P. Arsenjans, V. Ozola, E. Suna, I. Kalvins, Thienopy-
rroles Useful in the Treatment of Inﬂammation, Biolipox AB, Solna, SE,
WO/2006/077412, 2006.
[3] D.W. Beight, J.M. Morin, Jr., J.S. Sawyer, E.C.R. Smith, Substituted Pyrrole Com-
pounds and Their Use as sPLA2 Inhibitors, Eli Lilly & Co., Indianapolis, US,
WO/2002/012249, 2002.
[4] A.J. Barker, J.G. Kettle, A.W. Faull, Indole Derivatives and Their Use as MCP-1
Antagonist, Zeneca Ltd., UK, WO/99/40914, 1999.
Author's personal copy
226 E.M.S. Castanheira et al. / Journal of Photochemistry and Photobiology A: Chemistry 206 (2009) 220–226
[5] A.M. Birch, A.D. Morley, A. Stocker, P.R.O. Whittamore, Heterocyclic Amide
Derivatives as Inhibitors ofGlycogenPhosphorylase,AstrazenecaAB,WO/2003/
074532, 2003.
[6] J.C. Arnould, Thieno-pyrrole Compounds as Antagonists of Gonadotropin
Releasing Hormone, Astrazeneca AB, WO/2004/018479, 2004.
[7] J.B. Blair, D. Marona-Lewicka, A. Kanthasamy, V.L. Lucaites, D.L. Nelson, D.E.
Nichols, Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the
hallucinogen and serotonin agonist N,N-dimethyltryptamine, J. Med. Chem. 42
(1999) 1106–1111.
[8] Y.-Q. Fang, J. Yuen, M. Lautens, A general modular method of azaindole
and thienopyrrole synthesis via Pd-catalyzed tandem couplings of gem-
dichlorooleﬁns, J. Org. Chem. 72 (2007), 5152–5160 (and references cited
therein).
[9] K.E. Chippendale, B. Iddon, H. Suschitzky, Condensed thiophene ring systems.
Part X. Synthesis and reactions of 2-aryl-1H-[1]benzothieno[2,3-b]pyrroles
and 2-aryl-1H-[1]benzothieno[3,2-b]pyrroles, J. Chem. Soc. Perkin I (1973)
125–129.
[10] A.S. Abreu, N.O. Silva, P.M.T. Ferreira, M.-J.R.P. Queiroz, M. Venanzi, New ,-
Bis(benzo[b]thienyl)dehydroalaninederivatives: synthesis and cyclization, Eur.
J. Org. Chem. (2003) 4792–4796.
[11] R. Banerjee, Liposomes: applications in medicine, J. Biomater. Appl. 16 (2001)
3–21.
[12] B.R. Lentz, Membrane “ﬂuidity” as detected by diphenylhexatriene probes,
Chem. Phys. Lipids 50 (1989) 171–190.
[13] J.N. Demas, G.A. Crosby, The measurement of photoluminescence quantum
yields. A review, J. Phys. Chem. 75 (1971) 991–1024.
[14] S. Fery-Forgues, D. Lavabre, Are ﬂuorescence quantum yields so tricky to mea-
sure? A demonstration using familiar stationery products, J. Chem. Educ. 76
(1999) 1260–1264.
[15] J.V. Morris, M.A. Mahaney, J.R. Huber, Fluorescence quantum yield determina-
tions. 9,10-Diphenylanthracene as a reference standard in different solvents, J.
Phys. Chem. 80 (1976) 969–974.
[16] J.R. Lakowicz, Principles of Fluorescence Spectroscopy, 2ndedition, KluwerAca-
demic/Plenum Press, New York, 1999.
[17] N. Mataga, T. Kubota, Molecular Interactions and Electronic Spectra, Marcel
Dekker, New York, 1970.
[18] P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. War-
ren, H. Bokesch, S. Kenny, M.R. Boyd, New colorimetric cytotoxicity assay for
anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107–1112.
[19] A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paul, D. Vistica, C. Hose, J.
Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo, M.
Boyd, Feasibility of a high-ﬂux anticancer drug screen using a diverse panel of
cultured human tumor cell lines, J. Natl. Cancer Inst. 83 (1991) 757–766.
[20] M.-J.R.P. Queiroz, A.S. Abreu, M.S.D. Carvalho, P.M.T. Ferreira, N. Nazareth, M.S.-
J. Nascimento, Synthesis of new heteroaryl and heteroannulated indoles from
dehydrophenylalanines: antitumor evaluation, Bioorg. Med. Chem. 16 (2008)
5584–5589.
[21] M.-J.R.P. Queiroz, R.C. Calhelha, L.A. Vale-Silva, E. Pinto, M.S.-J. Nascimento,
Synthesis of novel 3-(aryl)benzothieno[2,3-c]pyran-1-ones from Sonogashira
products and intramolecular cyclization: antitumoral activity evaluation, Eur.
J. Med. Chem. 44 (2009) 1893–1899.
[22] C.A. Frederick, L.D. Williams, G. Ughetto, G.A. van der Marel, J.H. van Boom,
A. Rich, A.H. Wang, Structural comparison of anticancer drug-DNA complexes:
adriamycin and daunomycin, Biochemistry 29 (1990) 2538–2549.
[23] B. Valeur, Molecular Fluorescence—Principles and Applications, Wiley–VCH,
Weinheim, 2002.
[24] N.J. Turro,ModernMolecular Photochemistry, Benjamin/CummingsPub,Menlo
Park, CA, 1978.
[25] M.-J.R.P. Queiroz, E.M.S. Castanheira, A.M.R. Pinto, I.C.F.R. Ferreira, A. Begouin,
G. Kirsch, Synthesis of the ﬁrst thieno--carboline. Fluorescence studies in
solution and in lipid vesicles, J. Photochem. Photobiol. A: Chem. 181 (2006)
290–296.
[26] M.-J.R.P. Queiroz, E.M.S. Castanheira, T.C.T. Lopes, Y.K. Cruz, G. Kirsch, Synthesis
of ﬂuorescent tetracyclic lactams by a “one pot” three steps palladium-
catalyzed borylation, Suzuki coupling (BSC) and lactamization. DNA and
polynucleotides binding studies, J. Photochem. Photobiol. A: Chem. 190 (2007)
45–52.
[27] D.R. Lide (Ed.), Handbook of Chemistry and Physics, 83rd edition, CRC Press,
Boca Raton, 2002.
[28] (a) K.C. James, P.R. Noyce, Hydrogen bonding between testosterone propionate
andsolvent in chloroform-cyclohexanesolutions, Spectrochim.ActaA27 (1971)
691–696;
(b) G.R. Wileylb, S.I. Miller, Thermodynamic parameters for hydrogen bonding
of chloroform with Lewis Bases in cyclohexane. A proton magnetic resonance
study, J. Am. Chem. Soc. 94 (1972) 3287–3293.
[29] M.W. Schmidt, K.K. Baldridge, J.A. Boatz, S.T. Elbert, M.S. Gordon, J.H. Jensen,
S. Koseki, N. Matsunaga, K.A. Nguyen, S. Su, T.L. Windus, M. Dupuis, J.A. Mont-
gomery, General atomic and molecular electronic structure system, J. Comput.
Chem. 14 (1993) 1347–1363.
[30] F. Jensen, Introduction to Computational Chemistry, John Wiley & Sons, West
Sussex, England, 1999.
[31] Z.R. Grabowski, K. Rotkiewicz, W. Rettig, Structural changes accompanying
intramolecular electron transfer; focus on TICT states and structures, Chem.
Rev. 103 (2003) 3899–4031.
[32] M.-J.R.P. Queiroz, E.M.S. Castanheira, M.S.D. Carvalho, A.S. Abreu, P.M.T.
Ferreira, H. Karadeniz, A. Erdem, New tetracyclic heteroaromatic
compounds based on dehydroamino acids. Photophysical and elec-
trochemical studies of interaction with DNA, Tetrahedron 64 (2008)
382–391.
[33] J.R. Silvius, Thermotropic phase transitions of pure lipids in model membranes
and their modiﬁcations by membrane proteins, in: Lipid–Protein Interactions,
John Wiley & Sons, New York, 1982.
[34] G.E.S. Toombes, A.C. Finnefrock, M.W. Tate, S.M. Gruner, Determina-
tion of L–HII phase transition temperature for 1,2-dioleoyl-sn-glycero-3-
phosphatidylethanolamine, Biophys. J. 82 (2002) 2504–2510.
[35] D. Papahadjopoulos, N. Miller, Phospholipid model membranes. I. Structural
characteristics of hydrated liquid crystals, Biochim. Biophys. Acta 135 (1967)
624–638.
[36] S.J. Strickler, R.A. Berg, Relationship between absorption intensity and ﬂuores-
cence lifetime of molecules, J. Chem. Phys. 37 (1962) 814.
[37] E.M.S. Castanheira, A.S. Abreu,M.S.D. Carvalho,M.-J.R.P. Queiroz, P.M.T. Ferreira,
Fluorescence studies on potential antitumoral heteroaryl and heteroannu-
lated indoles in solution and in lipid membranes, J. Fluorescence 19 (2009)
501–509.
[38] J.M. Seddon, Structure of the inverted hexagonal (HII) phase and non-lamellar
phase transitions in lipids, Biochim. Biophys. Acta 1031 (1990) 1–69.
